跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ACZONE dapsone 7.5% w/w gel topical bottle with integral pump
Approved
STANDARD
ACZONE dapsone 7.5% w/w gel topical bottle with integral pump
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a2afeb42934dcad7
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
a2afeb42934dcad7
Product Name
ACZONE dapsone 7.5% w/w gel topical bottle with integral pump
Artg Id
266267
Artg Name
ACZONE dapsone 7.5% w/w topical gel bottle
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2017-01-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d53bf0049ace343c5f0dc27d10474058.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/84cc670b2c95fbe503b2556740728b61.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a2afeb42934dcad7
Type
Standard
Back to TGA Approvals
ACZONE dapsone 7.5% w/w gel topical bottle with integral pump - TGA Drug Approval Details
